Literature DB >> 11553861

Severe hypoxia specifically downregulates hepatocyte nuclear factor-4 gene expression in HepG2 human hepatoma cells.

N M Mazure1, T L Nguyen, J L Danan.   

Abstract

The liver is one of the organs in which hypoxia helps to regulate gene expression under normal physiological conditions and in diseases such as cirrhosis and cancer. We postulated that the expression/activity of some of the 'liver-enriched' transcription factors, which control liver-specific genes, was sensitive to hypoxia. We tested hepatocyte nuclear factor-1 (HNF-1), HNF-3 and HNF-4, which play key roles in differentiation, development and hepatic gene expression, using HepG2 human hepatoma cells cultured under hypoxic conditions. Severe hypoxia/anoxia downregulated HNF-4 DNA-binding activity while DNA-binding activity of HNF-1 and HNF-3 remained unaffected. These hypoxic conditions also strongly and specifically decreased cell contents of HNF-4 protein, indicating that the decrease in HNF-4 DNA-binding activity was due to the lower amount of protein and not to decreased DNA-binding affinity. Northern analysis indicated that the expression of the hnf-4 gene was also downregulated in HepG2 cells cultured under hypoxic conditions. These results provide evidence that hypoxic stress triggers a cascade of events that inhibits the transactivation potential of HNF-4 in HepG2 cells. This step may be crucial in modulating the expression of a subset of liver genes that are targets for this nuclear receptor. This relationship provides a new route for the investigation of the effects of hypoxia on the liver cell. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553861     DOI: 10.1159/000050632

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  7 in total

1.  Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Authors:  Yutaka Maeda; Wendy W Hwang-Verslues; Gang Wei; Takuya Fukazawa; Mary L Durbin; Laurie B Owen; Xuan Liu; Frances M Sladek
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

Review 2.  HNF4α--role in drug metabolism and potential drug target?

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

3.  Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha.

Authors:  Hong Lu; Frank J Gonzalez; Curtis Klaassen
Journal:  Toxicol Sci       Date:  2010-10-08       Impact factor: 4.849

4.  Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the predominant isoform of the nuclear receptor RORalpha in the liver and is up-regulated by hypoxia in HepG2 human hepatoma cells.

Authors:  Caroline Chauvet; Brigitte Bois-Joyeux; Jean-Louis Danan
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

5.  MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.

Authors:  Haitao Xu; Liang Zhao; Qiuju Fang; Jianmin Sun; Songyan Zhang; Chao Zhan; Shujie Liu; Yubao Zhang
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

6.  The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells.

Authors:  Carolina Simioni; Alice Cani; Alberto M Martelli; Giorgio Zauli; Ayman A M Alameen; Simona Ultimo; Giovanna Tabellini; James A McCubrey; Silvano Capitani; Luca M Neri
Journal:  Oncotarget       Date:  2015-07-10

7.  Multi-organ proteomic landscape of COVID-19 autopsies.

Authors:  Xiu Nie; Liujia Qian; Rui Sun; Bo Huang; Xiaochuan Dong; Qi Xiao; Qiushi Zhang; Tian Lu; Liang Yue; Shuo Chen; Xiang Li; Yaoting Sun; Lu Li; Luang Xu; Yan Li; Ming Yang; Zhangzhi Xue; Shuang Liang; Xuan Ding; Chunhui Yuan; Li Peng; Wei Liu; Xiao Yi; Mengge Lyu; Guixiang Xiao; Xia Xu; Weigang Ge; Jiale He; Jun Fan; Junhua Wu; Meng Luo; Xiaona Chang; Huaxiong Pan; Xue Cai; Junjie Zhou; Jing Yu; Huanhuan Gao; Mingxing Xie; Sihua Wang; Guan Ruan; Hao Chen; Hua Su; Heng Mei; Danju Luo; Dashi Zhao; Fei Xu; Yan Li; Yi Zhu; Jiahong Xia; Yu Hu; Tiannan Guo
Journal:  Cell       Date:  2021-01-09       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.